Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 20;11(3):e2021079.
doi: 10.5826/dpc.1103a79. eCollection 2021 May.

Can Dermoscopy Be Used to Predict if a Melanoma Is In Situ or Invasive?

Affiliations

Can Dermoscopy Be Used to Predict if a Melanoma Is In Situ or Invasive?

Sam Polesie et al. Dermatol Pract Concept. .

Abstract

Background: The preoperative prediction of whether melanomas are invasive or in situ can influence initial management.

Objectives: This study evaluated the accuracy rate, interobserver concordance, sensitivity and specificity in determining if a melanoma is invasive or in situ, as well as the ability to predict invasive melanoma thickness based on clinical and dermoscopic images.

Methods: In this retrospective, single-center investigation, 7 dermatologists independently reviewed clinical and dermoscopic images of melanomas to predict if they were invasive or in situ and, if invasive, their Breslow thickness. Fleiss' and Cohen's kappa (κ) were used for interobserver concordance and agreement with histopathological diagnosis.

Results: We included 184 melanomas (110 invasive and 74 in situ). Diagnostic accuracy ranged from 67.4% to 76.1%. Accuracy rates for in situ and invasive melanomas were 57.5% (95% confidence interval [CI], 53.1%-61.8%) and 81.7% (95% CI, 78.8%-84.4%), respectively. Interobserver concordance was moderate (κ = 0.47; 95% CI, 0.44-0.51). Sensitivity for predicting invasiveness ranged from 63.6% to 91.8% for 7 observers, while specificity was 32.4%-82.4%. For all correctly predicted invasive melanomas, agreement between predictions and correct thickness over or under 1.0 mm was moderate (κ = 0.52; 95% CI, 0.45-0.58). All invasive melanomas incorrectly predicted by any observer as in situ had a thickness <1.0 mm. All 32 melanomas >1.0 mm were correctly predicted to be invasive by all observers.

Conclusions: Accuracy rates for predicting thick melanomas were excellent, melanomas inaccurately predicted as in situ were all thin, and interobserver concordance for predicting in situ or invasive melanomas was moderate. Preoperative dermoscopy of suspected melanomas is recommended for choosing appropriate surgical margins.

Keywords: Breslow thickness; Dermoscopy; Inter Observer Variability; Melanoma; Projections and Predictions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Dermoscopic images of the 4 invasive melanomas that were predicted as in situ by all observers. All 4 lesions had a Breslow thickness ≤0.5 mm. Lesions (a) and (b) were located on the upper extremities, and lesions (c) and (d) were located on the scalp and arm, respectively.
Figure 2
Figure 2
Sensitivity and specificity for the classification of invasive melanomas, for 7 dermatologists and for the majority decision (ie, decision of ≥4 observers).

Similar articles

Cited by

References

    1. McGuire ST, Secrest AM, Andrulonis R, Ferris LK. Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery. Arch Dermatol. 2011;147(6):673–678. doi: 10.1001/archdermatol.2011.135. - DOI - PubMed
    1. Pizzichetta MA, Argenziano G, Talamini R, et al. Dermoscopic criteria for melanoma in situ are similar to those for early invasive melanoma. Cancer. 2001;91(5):992–997. - PubMed
    1. Lallas A, Longo C, Manfredini M, et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol. 2018;154:414–419. doi: 10.1001/jamadermatol.2017.6447. - DOI - PMC - PubMed
    1. Swedish guidelines for malignant melanoma [Article in Swedish] [Accessed: November 17, 2020]. Last updated April 29, 2019. https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/hud... .
    1. Garbe C, Amaral T, Peris K, et al. European Dermatology Form (EDF); European Association of Dermato-Oncology (EADO); European Organization for Research and Treatment of Cancer (EORTC) European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019. Eur J Cancer. 2020;126:159–177. doi: 10.1016/j.ejca.2019.11.015. - DOI - PubMed

LinkOut - more resources